Cargando…
Comparison of different laboratory tests in the evaluation of hemorrhagic risk of patients using rivaroxaban in the critical care setting: diagnostic accuracy study
BACKGROUND: Rivaroxaban is a direct oral anticoagulant designed to dispense with the necessity of laboratory monitoring. However, monitoring rivaroxaban levels is necessary in certain clinical conditions, especially in the critical care setting. METHODS: This is a diagnostic accuracy study evaluatin...
Autores principales: | Colombini, Marjorie Paris, Derogis, Priscilla Bento Matos Cruz, de Aranda, Valdir Fernandes, de Campos Guerra, João Carlos, Hamerschlak, Nelson, Mangueira, Cristóvão Luis Pitangueiras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557535/ https://www.ncbi.nlm.nih.gov/pubmed/28814943 http://dx.doi.org/10.1186/s12959-017-0140-6 |
Ejemplares similares
-
Determination of rivaroxaban in patient’s plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS)
por: Derogis, Priscilla Bento Matos, et al.
Publicado: (2017) -
Diagnostic accuracy of thromboelastometry and its correlation with the HPLC-MS/MS quantification test
por: de Aranda, V.F., et al.
Publicado: (2019) -
The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review
por: Bento, Laiz Cameirão, et al.
Publicado: (2017) -
Personalized medicine and the clinical laboratory
por: Pinho, João Renato Rebello, et al.
Publicado: (2014) -
Intracranial Hemorrhage in Patient Treated with Rivaroxaban
por: Molina, Michelle, et al.
Publicado: (2014)